Effect of anthracycline and taxane on the expression of programmed cell death ligand-1 and galectin-9 in triple-negative breast cancer. [electronic resource]
Producer: 20181107Description: 1626-1631 p. digitalISSN:- 1618-0631
- Adult
- Anthracyclines -- therapeutic use
- Antineoplastic Agents -- therapeutic use
- B7-H1 Antigen -- biosynthesis
- Bridged-Ring Compounds -- therapeutic use
- Cell Line, Tumor
- Chemotherapy, Adjuvant -- methods
- Female
- Galectins -- biosynthesis
- Humans
- Middle Aged
- Neoadjuvant Therapy -- methods
- Taxoids -- therapeutic use
- Triple Negative Breast Neoplasms -- drug therapy
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.